Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4523230 Target Snapshot

Utrophin · SINGLE PROTEIN · Homo sapiens

81Compounds
5Assays
0Approved Drugs
88.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Utrophin shows clinical signal disease relevance led by Duchenne muscular dystrophy. 1 linked drug keeps the current disease frame grounded. Protein identity stays anchored to UniProt P46939. Start with Duchenne muscular dystrophy, then reuse UniProt P46939 as the stable protein anchor across project notes and exports.

Review focus
Review-ready target frame

Start with Duchenne muscular dystrophy, then reuse UniProt P46939 as the stable protein anchor across project notes and exports.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14 1 linked drug
Open source guide
Disease program
Duchenne muscular dystrophy

Utrophin shows clinical signal disease relevance led by Duchenne muscular dystrophy. 1 linked drug remains visible in the same block.

Start review with Duchenne muscular dystrophy because it currently carries clinical signal support. Linked drugs include EZUTROMID. This disease block keeps the Open Targets-ready contract explicit while current evidence comes from ChEMBL mechanism and indication mappings.

Disease source · ChEMBL drug mechanism + indication proxy
Clinical signal Open Targets-ready proxy 1 linked drug
Open disease block
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Utrophin as ChEMBL target CHEMBL4523230, mapped to UniProt P46939. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Utrophin
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL4523230
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P46939
Utrophin
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Utrophin is the right protein anchor across sources, using UniProt P46939 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need to confirm why Duchenne muscular dystrophy is currently framed as clinical signal support. It currently carries 1 linked drug in the same disease frame.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelUtrophin
UniProt AccessionP46939
Component TypeProtein
Sequence Length3433 aa

Utrophin

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Utrophin, mapped to UniProt P46939. Sequence length is 3433 aa.

Mapped IDP46939
Review nameUtrophin
OrganismHomo sapiens
Disease Relevance

Disease Relevance & Evidence Level

Open Targets-ready disease context using the current target-indication evidence contract.

Clinical signal Open Targets-ready proxy

Utrophin shows clinical signal disease relevance led by Duchenne muscular dystrophy.

Clinical signal Phase II
Duchenne muscular dystrophy
1 linked drug · 1 direct · 1 efficacy
Linked drugEZUTROMID
Source · ChEMBL drug mechanism + indication proxy
Review Cue

How to read disease relevance

Start review with Duchenne muscular dystrophy because it currently carries clinical signal support. Linked drugs include EZUTROMID. This disease block keeps the Open Targets-ready contract explicit while current evidence comes from ChEMBL mechanism and indication mappings.

Lead diseaseDuchenne muscular dystrophy
Strongest levelClinical signal
Block modeOpen Targets-ready proxy
Clinical Profile

Clinical Phase Distribution

1
Phase II
Assay Mix

Activity Type Distribution

EC5088.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL4639067 8.4 EC50 4.0 Preclinical
CHEMBL4639832 8.0 EC50 10.0 Preclinical
CHEMBL4641041 7.58 EC50 26.0 Preclinical
CHEMBL4645628 7.47 EC50 34.0 Preclinical
CHEMBL4637833 7.42 EC50 38.0 Preclinical
CHEMBL4647136 7.21 EC50 62.0 Preclinical
CHEMBL4638445 7.15 EC50 71.0 Preclinical
CHEMBL4643175 7.15 EC50 71.0 Preclinical
CHEMBL4638708 7.07 EC50 85.0 Preclinical
CHEMBL4634557 6.97 EC50 108.0 Preclinical
Distribution

pChEMBL Value Distribution

3
5.0
18
5.5
17
6.0
22
6.5
6
7.0
1
7.5
2
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

5
Total Assays
60
Tested Compounds
2
Assay Types
Binding — 3 assays, 60 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 2 60 6.4
subcellular format 1 0
ADME — 2 assays, 5 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 1 2 5.5
single protein format 1 3 6.8

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine